Press "Enter" to skip to content

Posts published in “Industry News”

Explained: What Covaxin’s 81% interim vaccine efficacy means?

Bharat Biotech on Wednesday announced its Covid-19 vaccine candidate BBV152 Covaxin demonstrated 81% interim vaccine efficacy in its Phase 3 clinical trial. Original source: https://health.economictimes.indiatimes.com/news/pharma/81329879?utm_source=RSS&utm_medium=ETRSS

Bharat Biotech says Covid-19 vaccine shows 81% interim efficacy

The trials involved 25,800 participants and was conducted in partnership with the Indian government’s medical research body. Original source: https://health.economictimes.indiatimes.com/news/pharma/81311876?utm_source=RSS&utm_medium=ETRSS